Endeavour Vision is a private equity firm, focused exclusively on supporting growth-stage medtech companies. Their mission is to transform the standard of care for millions of patients by investing in ground-breaking medical innovations. The firm's recent investments include Relievant, Medartis (IPO in 2018), Vertiflex (acquired by Boston Scientific in 2019) and Symetis (acquired by Boston Scientific in 2017). The company headquarters are in Geneva, Switzerland with further presence in North America.
Venture Capital
2 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.